Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Blonanserin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101747273B reveals a novel two-step synthesis for Blonanserin intermediates, boosting yield from 17% to 80% and ensuring reliable pharmaceutical intermediates supply.
Novel safe synthesis route for Blonanserin intermediate using potassium tert-butoxide. High purity scalable process for pharmaceutical supply chains.
Patent CN111233707B reveals a high-yield synthesis of 4-fluorobenzoylacetonitrile using triflic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing.